LVAD Versus GDMT in Ambulatory Advanced Heart Failure Patients (AMBU-VAD)
Left Ventricular Assist Device (LVAD) Versus Guideline Recommended Medical Therapy in Ambulatory Advanced Heart Failure Patients (GDMT)
Sponsor: Hospices Civils de Lyon
Listed as NCT04768322, this NA trial focuses on End-stage Heart Failure and remains actively recruiting participants. Sponsored by Hospices Civils de Lyon, it has been updated 9 times since 2021, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
9 versions recorded-
Jan 2025 — Present [monthly]
Recruiting NA
-
Sep 2024 — Jan 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jun 2024 — Jul 2024 [monthly]
Recruiting NA
-
Sep 2023 — Jun 2024 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Jan 2023 — Sep 2023 [monthly]
Recruiting NA
-
Jun 2022 — Jan 2023 [monthly]
Recruiting NA
-
Feb 2022 — Jun 2022 [monthly]
Recruiting NA
-
Mar 2021 — Feb 2022 [monthly]
Recruiting NA
First recorded
Feb 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hospices Civils de Lyon
For direct contact, visit the study record on ClinicalTrials.gov .